13F HOLDINGS REPORT
Exome Asset Management LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001420506-24-000954
Total Value
$116.8M
Positions
53
Other Managers
0
Confidential Omitted
No
Holdings (53)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ELI LILLY & CO | LLY | 9,700 | $7.5M | 6.46% |
| 2 | DR REDDYS LABS LTD | 256135203 | 86,000 | $6.3M | 5.40% |
| 3 | BEIGENE LTD | BEIGF | 36,800 | $5.8M | 4.93% |
| 4 | THE CIGNA GROUP | 125523100 | 15,300 | $5.6M | 4.76% |
| 5 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 117,000 | $4.6M | 3.97% |
| 6 | TG THERAPEUTICS INC | TGTX | 230,300 | $3.5M | 3.00% |
| 7 | AVIDITY BIOSCIENCES INC | 05370A108 | 135,169 | $3.4M | 2.95% |
| 8 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 87,846 | $3.4M | 2.95% |
| 9 | DEXCOM INC | DXCM | 24,828 | $3.4M | 2.95% |
| 10 | CENTESSA PHARMACEUTICALS PLC | CNTA | 274,900 | $3.1M | 2.66% |
| 11 | CELLDEX THERAPEUTICS INC NEW | CLDX | 71,100 | $3.0M | 2.56% |
| 12 | GERON CORP | GERN | 886,800 | $2.9M | 2.51% |
| 13 | AEROVATE THERAPEUTICS INC | 008064107 | 98,485 | $2.9M | 2.49% |
| 14 | MORPHOSYS AG | 617760202 | 154,800 | $2.8M | 2.40% |
| 15 | TRAVERE THERAPEUTICS INC | TVTX | 362,487 | $2.8M | 2.39% |
| 16 | KRYSTAL BIOTECH INC | KRYS | 14,700 | $2.6M | 2.24% |
| 17 | INTUITIVE SURGICAL INC | ISRG | 6,358 | $2.5M | 2.17% |
| 18 | TARSUS PHARMACEUTICALS INC | TARS | 66,300 | $2.4M | 2.06% |
| 19 | MADRIGAL PHARMACEUTICALS INC | MDGL | 7,900 | $2.1M | 1.81% |
| 20 | INOZYME PHARMA INC | 45790W108 | 273,413 | $2.1M | 1.79% |
| 21 | RHYTHM PHARMACEUTICALS INC | RYTM | 45,603 | $2.0M | 1.69% |
| 22 | INSMED INC | INSM | 71,700 | $1.9M | 1.67% |
| 23 | ELEVATION ONCOLOGY INC | 28623U101 | 369,322 | $1.9M | 1.62% |
| 24 | EXACT SCIENCES CORP | 30063P105 | 26,700 | $1.8M | 1.58% |
| 25 | CYTOKINETICS INC | CYTK | 26,008 | $1.8M | 1.56% |
| 26 | REGENXBIO INC | RGNX | 84,470 | $1.8M | 1.52% |
| 27 | BIOGEN INC | BIIB | 8,200 | $1.8M | 1.51% |
| 28 | OCULAR THERAPEUTIX INC | OCUL | 193,600 | $1.8M | 1.51% |
| 29 | AGIOS PHARMACEUTICALS INC | AGIO | 59,902 | $1.8M | 1.50% |
| 30 | NATERA INC | NTRA | 18,650 | $1.7M | 1.46% |
| 31 | PENUMBRA INC | PEN | 7,353 | $1.6M | 1.41% |
| 32 | GUARDANT HEALTH INC | GH | 79,000 | $1.6M | 1.40% |
| 33 | OLEMA PHARMACEUTICALS INC | OLMA | 143,400 | $1.6M | 1.39% |
| 34 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 55,700 | $1.6M | 1.36% |
| 35 | BRIDGEBIO PHARMA INC | BBIO | 48,807 | $1.5M | 1.29% |
| 36 | TERNS PHARMACEUTICALS INC | TERN | 227,821 | $1.5M | 1.28% |
| 37 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 163,100 | $1.5M | 1.26% |
| 38 | INARI MED INC | 45332Y109 | 30,100 | $1.4M | 1.24% |
| 39 | QUANTERIX CORP | QTRX | 59,650 | $1.4M | 1.20% |
| 40 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 20,300 | $1.4M | 1.20% |
| 41 | SHOCKWAVE MED INC | 82489T104 | 4,000 | $1.3M | 1.12% |
| 42 | VYNE THERAPEUTICS INC | VYNE | 415,434 | $1.3M | 1.09% |
| 43 | REGULUS THERAPEUTICS INC | 75915K309 | 402,504 | $1.2M | 0.99% |
| 44 | Q32 BIO INC | QTTB | 65,021 | $1.1M | 0.95% |
| 45 | ZAI LAB LTD | ZLAB | 65,300 | $1.0M | 0.90% |
| 46 | ENLIVEN THERAPEUTICS INC | ELVN | 57,635 | $1.0M | 0.87% |
| 47 | VENTYX BIOSCIENCES INC | 92332V107 | 163,922 | $901,571 | 0.77% |
| 48 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 17,800 | $831,082 | 0.71% |
| 49 | I MAB | NBP | 325,762 | $605,917 | 0.52% |
| 50 | ADAGENE INC | ADAG | 155,383 | $435,072 | 0.37% |
| 51 | SAGIMET BIOSCIENCES INC | SGMT | 60,900 | $330,078 | 0.28% |
| 52 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 75,300 | $282,375 | 0.24% |
| 53 | AVROBIO INC | 05455M100 | 61,135 | $78,253 | 0.07% |